Yonsei Med J.  2016 Mar;57(2):291-297. 10.3349/ymj.2016.57.2.291.

Therapeutic Hypothermia for Cardioprotection in Acute Myocardial Infarction

• Kang IS
• Fumiaki I
• Pyun WB

• KMID: 2374031
• DOI: http://doi.org/10.3349/ymj.2016.57.2.291

Abstract

Mild therapeutic hypothermia of 32-35degrees C improved neurologic outcomes in outside hospital cardiac arrest survivor. Furthermore, in experimental studies on infarcted model and pilot studies on conscious patients with acute myocardial infarction, therapeutic hypothermia successfully reduced infarct size and microvascular resistance. Therefore, mild therapeutic hypothermia has received an attention as a promising solution for reduction of infarction size after acute myocardial infarction which are not completely solved despite of optimal reperfusion therapy. Nevertheless, the results from randomized clinical trials failed to prove the cardioprotective effects of therapeutic hypothermia or showed beneficial effects only in limited subgroups. In this article, we reviewed rationale for therapeutic hypothermia and possible mechanisms from previous studies, effective methods for clinical application to the patients with acute myocardial infarction, lessons from current clinical trials and future directions.

Keyword

Hypothermia, induced; myocardial infarction; myocardial reperfusion injury

MeSH Terms

Acute Disease
Body Temperature
Humans
Hypothermia, Induced/*methods
Male
Middle Aged
Myocardial Infarction/*therapy
Myocardial Reperfusion Injury/*prevention & control
Time Factors
Treatment Outcome

Reference

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012; 60:1581–1598.

2. Minicucci MF, Azevedo PS, Polegato BF, Paiva SA, Zornoff LA. Heart failure after myocardial infarction: clinical implications and treatment. Clin Cardiol. 2011; 34:410–414.

3. Lee S, Baek K, Chun K. Cost-effectiveness of drug-eluting vs. bare-metal stents in patients with coronary artery disease from the Korean National Health Insurance Database. Yonsei Med J. 2014; 55:1533–1541.

4. Oh PC, Choi IS, Ahn T, Moon J, Park Y, Seo JG, et al. Predictors of recovery of left ventricular systolic dysfunction after acute myocardial infarction: from the korean acute myocardial infarction registry and korean myocardial infarction registry. Korean Circ J. 2013; 43:527–533.

5. Lopez AD. Assessing the burden of mortality from cardiovascular diseases. World Health Stat Q. 1993; 46:91–96.

6. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58:e44–e122.

7. Berger PB, Ellis SG, Holmes DR Jr, Granger CB, Criger DA, Betriu A, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation. 1999; 100:14–20.

8. Sim DS, Ahn Y, Kim YH, Seon HJ, Park KH, Yoon HJ, et al. The Relationship among N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein and Infarct Size in Patients with Acute ST-Elevation Myocardial Infarction. Korean Circ J. 2015; 45:285–293.

9. Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ. 2009; 338:b1807.

10. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007; 357:1121–1135.

11. Yoon HJ, Jeong MH, Jeong Y, Kim KH, Song JE, Cho JY, et al. Progressive dilation of the left atrium and ventricle after acute myocardial infarction is associated with high mortality. Korean Circ J. 2013; 43:731–738.

12. Inoue T. Ischemia-reperfusion injury is still a big hurdle to overcome for treatment of acute myocardial infarction. J Cardiol. 2015; Dec. 13. [Epub]. DOI: 10.1016/j.jjcc.2015.09.002.

13. Kimura K, Nakao K, Shibata Y, Sone T, Takayama T, Fukuzawa S, et al. Randomized controlled trial of TY-51924, a novel hydrophilic NHE inhibitor, in acute myocardial infarction. J Cardiol. 2015; Sep. 7. [Epub]. DOI: 10.1016/j.jjcc.2015.07.017.

14. Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW, Kloeck WG, Billi J, et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation. 2003; 108:118–121.

15. Schwartz BG, Kloner RA, Thomas JL, Bui Q, Mayeda GS, Burstein S, et al. Therapeutic hypothermia for acute myocardial infarction and cardiac arrest. Am J Cardiol. 2012; 110:461–466.

16. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002; 346:549–556.

17. Duncker DJ, Klassen CL, Ishibashi Y, Herrlinger SH, Pavek TJ, Bache RJ. Effect of temperature on myocardial infarction in swine. Am J Physiol. 1996; 270(4 Pt 2):H1189–H1199.

18. Hale SL, Kloner RA. Ischemic preconditioning and myocardial hypothermia in rabbits with prolonged coronary artery occlusion. Am J Physiol. 1999; 276(6 Pt 2):H2029–H2034.

19. Tissier R, Couvreur N, Ghaleh B, Bruneval P, Lidouren F, Morin D, et al. Rapid cooling preserves the ischaemic myocardium against mitochondrial damage and left ventricular dysfunction. Cardiovasc Res. 2009; 83:345–353.

20. Herring MJ, Hale SL, Dai W, Oskui PM, Kloner RA. Hypothermia in the setting of experimental acute myocardial infarction: a comprehensive review. Ther Hypothermia Temp Manag. 2014; 4:159–167.

21. Hale SL, Dae MW, Kloner RA. Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction. Cardiovasc Res. 2003; 59:715–722.

22. Götberg M, Olivecrona GK, Koul S, Carlsson M, Engblom H, Ugander M, et al. A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv. 2010; 3:400–407.

23. Erlinge D, Götberg M, Lang I, Holzer M, Noc M, Clemmensen P, et al. Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial: a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. J Am Coll Cardiol. 2014; 63:1857–1865.

24. Erlinge D, Götberg M, Noc M, Lang I, Holzer M, Clemmensen P, et al. Therapeutic hypothermia for the treatment of acute myocardial infarction-combined analysis of the RAPID MI-ICE and the CHILL-MI trials. Ther Hypothermia Temp Manag. 2015; 5:77–84.

25. Nichol G, Strickland W, Shavelle D, Maehara A, Ben-Yehuda O, Genereux P, et al. Prospective, multicenter, randomized, controlled pilot trial of peritoneal hypothermia in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv. 2015; 8:e001965.

26. Kim CY, Bae MH, Kim NK, Yang YA, Kim KY, Lee JH, et al. Case of recurrent ventricular fibrillations with osborn wave developed during therapeutic hypothermia. Korean Circ J. 2015; 45:81–84.

27. Tissier R, Chenoune M, Ghaleh B, Cohen MV, Downey JM, Berdeaux A. The small chill: mild hypothermia for cardioprotection? Cardiovasc Res. 2010; 88:406–414.

28. Hamamoto H, Sakamoto H, Leshnower BG, Parish LM, Kanemoto S, Hinmon R, et al. Very mild hypothermia during ischemia and reperfusion improves postinfarction ventricular remodeling. Ann Thorac Surg. 2009; 87:172–177.

29. McAlindon E, Bucciarelli-Ducci C, Suleiman MS, Baumbach A. Infarct size reduction in acute myocardial infarction. Heart. 2015; 101:155–160.

30. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wave-front phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977; 56:786–794.

31. Tekin K, Cagliyan CE, Tanboga IH, Balli M, Uysal OK, Ozkan B, et al. Influence of the timing of percutaneous coronary intervention on clinical outcomes in non-ST-elevation myocardial infarction. Korean Circ J. 2013; 43:725–730.

32. Kim KH, Kim W, Kang WY, Hwang SH, Cho SC, Kim W, et al. The impact of ischemic time on the predictive value of high-sensitivity C-reactive protein in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention. Korean Circ J. 2013; 43:664–673.

33. Masoudi FA, Bonow RO, Brindis RG, Cannon CP, Debuhr J, Fitzgerald S, et al. ACC/AHA 2008 statement on Performance Measurement and Reperfusion Therapy: a report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of Performance Measurement and Reperfusion Therapy). J Am Coll Cardiol. 2008; 52:2100–2112.

34. Fröhlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013; 34:1714–1722.

35. Chun WJ, Nah DY, Bae JH, Chung JW, Lee H, Moon IS. Glucoseinsulin-potassium solution protects ventricular myocytes of neonatal rat in an in vitro coverslip ischemia/reperfusion model. Korean Circ J. 2015; 45:234–241.

36. Kim NH, Kang PM. Apoptosis in cardiovascular diseases: mechanism and clinical implications. Korean Circ J. 2010; 40:299–305.

37. Nah DY, Rhee MY. The inflammatory response and cardiac repair after myocardial infarction. Korean Circ J. 2009; 39:393–398.

38. Polderman KH, Noc M, Kurz M, Aibiki M. Therapeutic hypothermia in post-cardiac arrest and myocardial infarction. Ther Hypothermia Temp Manag. 2015; 5:193–197.

39. Simkhovich BZ, Hale SL, Kloner RA. Metabolic mechanism by which mild regional hypothermia preserves ischemic tissue. J Cardiovasc Pharmacol Ther. 2004; 9:83–90.

40. Yang X, Liu Y, Yang XM, Hu F, Cui L, Swingle MR, et al. Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity. Basic Res Cardiol. 2011; 106:421–430.

41. Solenkova NV, Solodushko V, Cohen MV, Downey JM. Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart Circ Physiol. 2006; 290:H441–H449.

42. Hale SL, Kloner RA. Mild hypothermia as a cardioprotective approach for acute myocardial infarction: laboratory to clinical application. J Cardiovasc Pharmacol Ther. 2011; 16:131–139.

43. Kanemoto S, Matsubara M, Noma M, Leshnower BG, Parish LM, Jackson BM, et al. Mild hypothermia to limit myocardial ischemia-reperfusion injury: importance of timing. Ann Thorac Surg. 2009; 87:157–163.

44. Götberg M, Olivecrona GK, Engblom H, Ugander M, van der Pals J, Heiberg E, et al. Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size. BMC Cardiovasc Disord. 2008; 8:7.

45. Hale SL, Herring MJ, Kloner RA. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. J Am Heart Assoc. 2013; 2:e004234.

46. Jin X, Yoon MH, Seo KW, Tahk SJ, Lim HS, Yang HM, et al. Usefulness of hyperemic microvascular resistance index as a predictor of clinical outcomes in patients with ST-segment elevation myocardial infarction. Korean Circ J. 2015; 45:194–201.

47. Baek YS, Park SD, Kim SH, Lee MJ, Shin SH, Kim DH, et al. Clinical and angiographic predictors of microvascular dysfunction in ST-segment elevation myocardial infarction. Yonsei Med J. 2015; 56:1235–1243.

48. Cheng R, Wei G, Yu L, Su Z, Wei L, Bai X, et al. Coronary flow reserve in the remote myocardium predicts left ventricular remodeling following acute myocardial infarction. Yonsei Med J. 2014; 55:904–911.

49. Howes D, Ohley W, Dorian P, Klock C, Freedman R, Schock R, et al. Rapid induction of therapeutic hypothermia using convectiveimmersion surface cooling: safety, efficacy and outcomes. Resuscitation. 2010; 81:388–392.

50. Ly HQ, Denault A, Dupuis J, Vadeboncoeur A, Harel F, Arsenault A, et al. A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study). Am Heart J. 2005; 150:933.

51. Castrén M, Nordberg P, Svensson L, Taccone F, Vincent JL, Desruelles D, et al. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010; 122:729–736.

52. Polderman KH, Rijnsburger ER, Peerdeman SM, Girbes AR. Induction of hypothermia in patients with various types of neurologic injury with use of large volumes of ice-cold intravenous fluid. Crit Care Med. 2005; 33:2744–2751.

53. Kandzari DE, Chu A, Brodie BR, Stuckey TA, Hermiller JB, Vetrovec GW, et al. Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study). Am J Cardiol. 2004; 93:636–639.

54. Wolff B, Machill K, Schumacher D, Schulzki I, Werner D. Early achievement of mild therapeutic hypothermia and the neurologic outcome after cardiac arrest. Int J Cardiol. 2009; 133:223–228.

55. O'Neill WW, Dixon SR. The year in interventional cardiology. J Am Coll Cardiol. 2004; 43:875–890.

56. O'Neill WW, Dixon SR, Grines CL. The year in interventional cardiology. J Am Coll Cardiol. 2005; 45:1117–1134.

57. Erlinge D, Götberg M, Grines C, Dixon S, Baran K, Kandzari D, et al. A pooled analysis of the effect of endovascular cooling on infarct size in patients with ST-elevation myocardial infarction. EuroIntervention. 2013; 8:1435–1440.

58. Straub A, Krajewski S, Hohmann JD, Westein E, Jia F, Bassler N, et al. Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target. Arterioscler Thromb Vasc Biol. 2011; 31:1607–1616.